Fig. 9
From: Harnessing exosomes for targeted drug delivery systems to combat brain cancer
DC-tumor hybrid cell-derived chimeric exosomes loaded with STING agonists (DT-Exo-STING) delivery system that is intended to increase the defense system’s T-cell attack against cancer cells